COPE Activators
COPE Activators are a diverse group of chemical compounds that indirectly augment the functional activity of COPE through various signaling pathways, primarily focusing on modulating intracellular levels of cAMP and cGMP. Forskolin, a well-known adenylyl cyclase activator, elevates intracellular cAMP, which in turn activates PKA. This activation can lead to phosphorylation events that enhance COPE's role in vesicular transport. Similarly, IBMX and Rolipram, through their inhibition of phosphodiesterases, raise cAMP levels, indirectly promoting COPE's functionality. (-)-Epigallocatechin Gallate, known for its kinase inhibition, may reduce competitive signaling pathways, allowing COPE to more effectively participate in vesicular trafficking. Compounds like Curcumin and Resveratrol modulate various cellular processes, creating an environment that indirectly supports COPE's functional role. Specifically, Curcumin's impact on NF-κB and Resveratrol's influence on sirtuin activity illustrate the complex interplay of signaling pathways in enhancing COPE's activity.
The second group of COPE activators, including Sildenafil, Caffeine, Yohimbine, Vinpocetine, Salbutamol, and Quercetin, also contribute to the enhancement of COPE's vesicular transport functions through their modulation of cAMP and cGMP levels. Sildenafil, a PDE-5 inhibitor, and Vinpocetine, targeting PDE-1, increase cGMP levels, potentially enhancing PKG activity which could support COPE. Caffeine's general phosphodiesterase inhibition, Yohimbine's antagonistic action on alpha-2 adrenergic receptors, and Salbutamol's β2-adrenergic agonism all serve to increase cAMP levels, indirectly enhancing COPE's role in vesicular trafficking. Quercetin, with its broad impact on cellular signaling, further underscores the diverse biochemical pathways that can be leveraged to indirectly augment COPE's functional activity in the cell. Together, these compounds illustrate the intricate network of intracellular signaling and its influence on COPE's role in cellular processes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin enhances intracellular cAMP levels, which indirectly promotes COPE activity. Elevated cAMP activates PKA, leading to phosphorylation events that can enhance COPE's functional role in vesicular transport. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This catechin inhibits various kinases, potentially reducing competition for substrates or signaling pathways that involve COPE, thereby indirectly enhancing its vesicular trafficking role. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, leading to increased cAMP and cGMP levels. This promotes PKA activity, which can indirectly enhance COPE function in vesicular transport. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
As a selective phosphodiesterase-4 inhibitor, Rolipram elevates intracellular cAMP, thereby enhancing PKA activity. This, in turn, indirectly supports COPE in its role in vesicular trafficking. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin affects multiple signaling pathways, including inhibition of NF-κB. This modulation can create a cellular environment that indirectly enhances COPE's functionality in vesicular transport. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol influences sirtuin activity, which indirectly modulates cellular processes involving COPE, potentially enhancing its role in vesicular trafficking. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine's inhibition of phosphodiesterases leads to elevated cAMP levels, indirectly enhancing PKA activity and potentially supporting COPE's role in vesicular transport. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine is an alpha-2 adrenergic receptor antagonist, which can increase levels of cAMP, indirectly enhancing COPE’s functionality in vesicular trafficking. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine inhibits phosphodiesterase-1, leading to increased cAMP and cGMP levels, indirectly supporting the functional role of COPE in vesicular transport. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol, as a β2-adrenergic agonist, increases intracellular cAMP levels, thereby potentially enhancing COPE activity in its role in vesicular trafficking. | ||||||